Start in Biological Technology
Navigation Links
Start in Biological Technology
SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
... at least 10 minutes prior to the call start time. The participant passcode for this ... at anytime, including up to and after the call start time, at ... Please connect to Senomyx's website prior to the start of the webcast to ensure adequate time to ...Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer
... a global Phase 3 trial of Stimuvax known as start (Stimulating Targeted Antigenic Responses To NSCLC). start is a randomized, double-blind, placebo-controlled ... in over 30 countries. For more information on the start trial, or to find a participating center and ...SENOMYX, INC. SECOND QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR AUGUST 4, 2009
... at least 10 minutes prior to the call start time. The participant passcode for this ... at anytime, including up to and after the call start time, at ... Please connect to Senomyx's website prior to the start of the webcast to ensure adequate time to ...China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
... manufacturing facility in Qingpu and expect to start trial production in Q2 FY2010 -- ... dial 888-241-0558 five to 10 minutes prior to the start time (to allow time for registration) and ... visit the site at least 15 minutes prior to the start of the call to register, download, and install ...Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer
... 3 STRIDE trial in breast cancer to the Phase 3 start trial in non-small cell lung cancer (NSCLC) is ... a global Phase 3 trial of Stimuvax known as start (Stimulating Targeted Antigenic Responses To NSCLC). start is a randomized, double-blind, placebo-controlled ...... a global Phase 3 trial of Stimuvax known as start (Stimulating Targeted Antigenic Responses To NSCLC). start is a randomized, double-blind, placebo-controlled ... a global Phase 3 trial of Stimuvax known as start (Stimulating Targeted Antigenic Responses To ...
SENOMYX ANNOUNCES FIRST QUARTER 2009 FINANCIAL RESULTS
... at least 10 minutes prior to the call start time. The participant passcode for this ... at anytime, including up to and after the call start time, at ... Please connect to Senomyx's website prior to the start of the webcast to ensure adequate time to ...SENOMYX, INC. FIRST QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR MAY 7, 2009
... , at least 10 minutes prior to the call start time. The participant passcode for this ... at anytime, including up to and after the call start time, at ... Please connect to Senomyx's website prior to the start of the webcast to ensure adequate time to ...ThromboGenics Announces Business Update and 2008 Full Year Results
... in back of the eye disease. The decision to start the Phase III program was based on the positive ... In January 2009, ThromboGenics announced the start of the Phase III clinical program of microplasmin ... announced in Phase Ia study with TB-403 and start of Phase Ib study in late stage cancer patients. ...SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS
... at least 10 minutes prior to the call start time. The participant passcode for this ... at anytime, including up to and after the call start time, at ... Please connect to Senomyx's website prior to the start of the webcast to ensure adequate time to ...... , at least 10 minutes prior to the call start time. The participant passcode for this ... at anytime, including up to and after the call start time, at ... Please connect to Senomyx's website prior to the start of the webcast to ensure adequate time to ...
SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS
... at least 10 minutes prior to the call start time. The participant passcode for this ... at anytime, including up to and after the call start time, at ... Please connect to Senomyx's website prior to the start of the webcast to ensure adequate time to ...SENOMYX, INC. THIRD QUARTER 2008 EARNINGS CONFERENCE CALL SCHEDULED FOR NOVEMBER 6, 2008
... at least 10 minutes prior to the call start time. The participant passcode for ... at anytime, including up to and after the call start time, at ... Please connect to Senomyx's website prior to the start of the webcast to ensure adequate time to ...Oncothyreon announces prioritization plan for development programs
... Stimuvax," continued Dr. Kirkman. "The Phase 3 start trial of Stimuvax in non-small cell lung cancer ... Targeted Antigenic Responses To NSCLC). start is a randomized, double-blind, placebo-controlled ... 30 countries. For more information on the start trial, or to find a participating center and ...... administered approximately one hour prior to the start of chemotherapy. ALOXI (palonosetron ... administered approximately 30 minutes before the start of chemotherapy. About Chemotherapy-Induced ... administered approximately one hour prior to the start of chemotherapy. ALOXI is contraindicated in ...
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
... In the anti-cancer program, we were able to start and complete patient enrollment in the planned ... Avid customers." Corporate Highlights Since the start of Fiscal Year 2008 -- In July 2008, Peregrine ... approximately 10 minutes prior to the scheduled start time and request to join the Peregrine ...Oncothyreon to receive milestone payment
... a global Phase 3 trial of Stimuvax known as start (Stimulating Targeted Antigenic Responses To NSCLC). start is a randomized, double-blind, placebo-controlled ... 30 countries. For more information on the start trial, or to find a participating center and ...... product required for the Phase II studies, due to start this summer, SynCo has developed and scaled up ... applications to obtain approval for the start of its AG011 clinical trial during this summer. ActoGeniX also plans to start a Phase II study with the same product in Crohn's ...
AtriCure Reports First Quarter 2008 Financial Results
... into the call and will facilitate the timely start of the conference. Pre-registration only takes a ... at any time, including up to and after the call start time. Alternatively, if you prefer being placed ... callers at least 15 minutes prior to the call start time and use reservation number 74210586. The ...Diamyd Gets Authorization to Begin Phase III Study in the US
... The FDA has given Diamyd Medical permission to start a Phase III clinical study in type 1 diabetes ... ) "We are eager to start this study and to be able to offer this promising ... in Europe. It is very satisfying to be able to start the studies now." The US Phase III study will ...Oncothyreon highlights corporate and clinical objectives for 2008
... patients with non-small cell lung cancer (NSCLC), start (Stimulating Targeted Antigenic Responses ... both Stimuvax and placebo to support start and potentially other additional trials of ... payment related to Stimuvax during 2008. start is a multi-center, randomized, double-blind, ...Start Licensing, Inc. Welcomes FDA's Finding of Safety of Food From Cloned Animals
... AUSTIN, Texas, Jan. 16 /PRNewswire-USNewswire/ -- start Licensing, Inc. ("Start"), a joint venture of ... traits, in their herds." Created in 2005, start is a joint venture of Geron Corporation (Nasdaq: GERN) and Exeter Life Sciences, Inc. start manages and licenses a worldwide portfolio of ...... has entered its Phase III development and the start (Stimulating Targeted Antigenic Responses to NSCLC) trial is currently open for enrollment. The start trial is being conducted by Merck KGaA of ... have significant unmet medical need, and the start study is the first Phase III program to evaluate ...
GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
... * In July, GeoVax announced an early start of two new HIV/AIDS vaccine clinical (human) ... compliant trials were previously scheduled to start later in 2007 and are the 3rd and 4th in a four ... particularly encouraged by the recent accelerated start date of our two new human clinical ...InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
... of ITMN-191 in combination with standard of care in August; our plans to start a Phase 1b MAD study of ITMN-191 in combination with low dose ritonavir in ... company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be ...Amicus Therapeutics Announces Second Quarter 2009 Financial Results
... (ERT) or who have not received ERT for at least six months prior to the start of treatment with Amigal. The Amigal treatment arm dose and regimen will ... participants are encouraged to go to the Web site 15 minutes prior to the start of the call to register, download and install any necessary software. ...Bacteria pack their own demise
... there are several closely related T-A systems), biomedical scientists can start looking for substances to start the time bomb of pathogens ticking, i.e. substances that imitate the toxin ...Sanofi-aventis Announces Second Quarter 2009 Results
... Increasing innovation in R&D: launch of a new R&D approach ; start of Phase III for BSI-201 in triple negative breast cancer; license and ... million. The sanofi-aventis transformation program Since the start of the year, we have been engaged in a wide-ranging transformation program ...... by telephone, please dial 888-241-0558 five to 10 minutes prior to the start time (to allow time for registration) and reference the conference ID ... live webcast, please go to this web site at least 15 minutes prior to the start of the call to register, download, and install any necessary audio ...
New Report Just Published: World Prostate Cancer Therapeutics Market Report
... Orchiectomy II-35 Side Effects of Orchiectomy II-35 Time to start Hormonal Therapy II-35 Strategies to Enhance Hormonal Treatment II-36 ... III Study of Trelstar in Prostate Cancer Treatment II-53 Algeta to start Clinical Study of Alpharadin in HRPC II-53 Ferring Receives FDA ...Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia
... while Palkion oversees the clinical development. Since the start of this agreement, CrystalGenomics has placed a high priority on this ... and improve patient compliance as well. "This sooner than expected start of preclinical development studies is an affirmation of CrystalGenomics' ...Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials
... and neutral effect on body weight - Global Phase III trials likely to start by end 2009 - IND approved by USFDA - Glenmark takes a step ... "Global Phase III trials have been planned with Melogliptin and are due to start at the end of 2009 following regulatory approvals. These studies ...Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing
... announcement John O'Dea, Head of Lifesciences in the High Potential start Up department in Enterprise Ireland said: "Opsona epitomises the type of ... (OPN-305) has demonstrated efficacy in a number of animal models and will start pivotal clinical trials in 2010. The company has also signed significant ...DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments
... compared with $2.9 million for 2007. "2009 is off to a strong start for DOR," stated Christopher J. Schaber, PhD, President and CEO of DOR. "To start the year off, we announced FDA clearance under its Special Protocol ...Batman Teams with Senator Katherine Laforge to Help Free America from OPEC
... because he was speaking out about alternative energy and the problems that start up companies have competing with their nemesis Big Oil. In the ... industry and Kent feels it is time for owners to quit watching and start participating in this energy revolution. Emerging from the pages of ...Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008
... patients with platinum-failed head & neck cancers; - start of patient enrolment in five new trials: - NCI-sponsored Phase ... - UK REOLYSIN and docetaxel clinical trial; - In early 2009, start of patient enrolment in a University of Leeds-sponsored ...... reports Add or remove studies from a portfolio Modify study start dates Adjust study probabilities "ClearTrial Portfolio ... proactively hire or contract for additional resources - or modify study start dates to smooth out resource utilization. Planners can instantly see the ...
Amsterdam Molecular Therapeutics Reports Full Year Results 2008
... on GlyberaTM - CEO Ronald Lorijn resigned for personal reasons - start of clinical multicenter Hemophilia B trial in 2009 - start development of treatments for Duchenne Muscular Dystrophy and ...AMERIGROUP Praises Expansion of State Children's Health Insurance Program (SCHIP)
... President Barack Obama: "All of America's children deserve a healthy start in life, and that happens only when they are able to see a family doctor ... that this legislation will enable millions more of them to get the healthy start they deserve." About AMERIGROUP Corporation AMERIGROUP ...Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in Lymphoma Presented at ASH
... (domestic) or 617-614-3523 (international) 10 minutes prior to the start time and use the passcode 36883961. A replay of the call will be ... . Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads ...Other ContentsmelasmameningitismeningitismeningitismelenameningiomameningesmenopausemenopausemenopausetearstearstearstearsOther TagsraceraceraceraceraceracewinwinwinwinwinwintagtagtagtagtagtagtagSNAPSNAPBridgesgoalcomponentsGapGapGapGapPlanPlanPlanPlanPlanPlanPlanPlanreceivereceivereceivereceiveOther Tagstogether 2together 3together 4together 5together 6together 7together 8together 9together 10agencies 2agencies 3agencies 4agencies 5agencies 6agencies 7agencies 8agencies 9agencies 10decay 2decay 3decay 4menopausal 2menopausal 3menopausal 4menopausal 5menopausal 6doctors 2doctors 3doctors 4doctors 5doctors 6doctors 7doctors 8doctors 9doctors 10losses 2losses 3despite 2despite 3despite 4despite 5despite 6despite 7despite 8despite 9despite 10night 2night 3
(Date:12/1/2009)...t for listening to the radio anymore. They,re used...search from North Carolina State University is rev... shape-shifting antennas that open the door to a h...ty to military deployment. , Modern antennas are...imitations to how far they can be bent and how of...
(Date:11/30/2009)...iversity researchers Ron Falta and Larry Murdoch h...Agency grant to study the safe storage of carbon d... the earth,s surface. , With carbon dioxide emis... leading cause of global warming, geologic storage...ves for reducing emissions using current technolog...
(Date:11/30/2009)...9) Scientists and engineers from two of the natio...come together Dec. 7 with leading academicians to ...ood. , Much like moving oil through a pipeline, ...systems need clean, well-functioning pipes (or blo...nction efficiently. Both industries also are cruci...
Breaking Biology News(10 mins):Shape shifters: Researchers create new breed of antennas 2Similarities of pumping blood and oil examined 2Similarities of pumping blood and oil examined 3Santa Barbara Medical Innovations Sponsors 2009 Microsoft Alumni Foundation Integral Fellows Awards Program 61583 1Santa Barbara Medical Innovations Sponsors 2009 Microsoft Alumni Foundation Integral Fellows Awards Program 61583 2Santa Barbara Medical Innovations Sponsors 2009 Microsoft Alumni Foundation Integral Fellows Awards Program 61583 3Is 80 year old mistake leading to first species to be fished to extinction 3F 10778 1Is 80 year old mistake leading to first species to be fished to extinction 3F 10778 2New study confirms exotic electric properties of graphene 14884 1New study confirms exotic electric properties of graphene 14884 2New study confirms exotic electric properties of graphene 14884 3(Date:12/1/2009)... Ever thought you could quit smoking while you...,s groundbreaking new system for quitting is easy,...t twenty eight days your cravings and desire to sm... (PRWEB) December 1, 2009 -- Izabella had t... addiction to nicotine, smoking at least a pack a ...
(Date:12/1/2009)...LLEY, Pa., Dec. 1 Air Pr...the previously announced sale of the assets of its...r the Airthane® and Versathane® tradenam...lobal polyurethane chemicals producer COIM SpA. ,...cturing facility in Paulsboro, N.J. Terms of the a...
(Date:12/1/2009)..., Dec. 1 The following ...onal Development: ,, Chairman Kerry, Ranking Me...am honored to be nominated by President Obama to s...for International Development, and I appreciate hi...etary of State Clinton has expressed the convictio...
(Date:12/1/2009)...UDERDALE, Fla., Dec. 1 OrbusNeich ...nt in the randomized clinical trial of the Combo B...). ,, A prospective, randomized, multicenter st...ablu M inal sirolimus coat ED bio- E nginee...0 sites in Asia, Australia, Europe and South Ameri...
(Date:12/1/2009)...ve that happiness declines with age are more likel...e drinking. Their misguided negative view of the a...sensibly, and encourage them to make the most of t... These findings 1 by Dr. John Garry and Dr. Mari...Ireland, are published online in Springer,s Journ...
Breaking Medicine News(10 mins):Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 4Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 5Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 6Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 7Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 8Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 9Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Binge drinking youths find getting old a drag 2[0] Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book[0] Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA[0] Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009[0] OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent[0] Binge drinking youths find getting old a drag
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |